Freshpet (NASDAQ:FRPT) & Medifast (NYSE:MED) Critical Analysis

Freshpet (NASDAQ:FRPTGet Free Report) and Medifast (NYSE:MEDGet Free Report) are both consumer staples companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings.

Institutional & Insider Ownership

95.5% of Medifast shares are owned by institutional investors. 4.4% of Freshpet shares are owned by company insiders. Comparatively, 2.9% of Medifast shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Analyst Ratings

This is a summary of current recommendations for Freshpet and Medifast, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Freshpet 1 6 8 0 2.47
Medifast 0 1 0 0 2.00

Freshpet currently has a consensus target price of $108.07, suggesting a potential upside of 102.31%. Medifast has a consensus target price of $16.50, suggesting a potential upside of 16.81%. Given Freshpet’s stronger consensus rating and higher possible upside, research analysts plainly believe Freshpet is more favorable than Medifast.

Risk and Volatility

Freshpet has a beta of 1.72, indicating that its share price is 72% more volatile than the S&P 500. Comparatively, Medifast has a beta of 0.82, indicating that its share price is 18% less volatile than the S&P 500.

Profitability

This table compares Freshpet and Medifast’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Freshpet 3.23% 4.82% 3.21%
Medifast 0.76% 2.00% 1.50%

Valuation & Earnings

This table compares Freshpet and Medifast”s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Freshpet $975.18 million 2.67 $46.92 million $0.67 79.73
Medifast $480.45 million 0.32 $2.09 million $0.32 44.14

Freshpet has higher revenue and earnings than Medifast. Medifast is trading at a lower price-to-earnings ratio than Freshpet, indicating that it is currently the more affordable of the two stocks.

Summary

Freshpet beats Medifast on 13 of the 14 factors compared between the two stocks.

About Freshpet

(Get Free Report)

Freshpet, Inc., together with its subsidiaries, manufactures, distributes, and markets natural fresh meals and treats for dogs and cats in the United States, Canada, and Europe. It sells dog food, cat food, and dog treats under the Freshpet brand name; and Dognation and Dog Joy labels through various classes of retail, including grocery, mass, club, pet specialty, and natural, as well as online. The company was incorporated in 2004 and is headquartered in Secaucus, New Jersey.

About Medifast

(Get Free Report)

Medifast, Inc., through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names. The company markets its products through point-of-sale transactions, as well as through ecommerce platform. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland.

Receive News & Ratings for Freshpet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Freshpet and related companies with MarketBeat.com's FREE daily email newsletter.